SK42897A3 - Process for producing enantiomerically clean cycloalkano indol- and azaindol-, and pyrimido£1,2-a|indolcarboxylic acids, and their activated derivatives, intermediate products for this process and their use - Google Patents

Process for producing enantiomerically clean cycloalkano indol- and azaindol-, and pyrimido£1,2-a|indolcarboxylic acids, and their activated derivatives, intermediate products for this process and their use Download PDF

Info

Publication number
SK42897A3
SK42897A3 SK428-97A SK42897A SK42897A3 SK 42897 A3 SK42897 A3 SK 42897A3 SK 42897 A SK42897 A SK 42897A SK 42897 A3 SK42897 A3 SK 42897A3
Authority
SK
Slovakia
Prior art keywords
formula
group
carbon atoms
straight
compounds
Prior art date
Application number
SK428-97A
Other languages
English (en)
Slovak (sk)
Inventor
Jan-Bernd Lenfers
Peter Fey
Paul Naab
Laak Kai Van
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK42897A3 publication Critical patent/SK42897A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/616—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK428-97A 1996-04-04 1997-04-03 Process for producing enantiomerically clean cycloalkano indol- and azaindol-, and pyrimido£1,2-a|indolcarboxylic acids, and their activated derivatives, intermediate products for this process and their use SK42897A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19613549A DE19613549A1 (de) 1996-04-04 1996-04-04 Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate

Publications (1)

Publication Number Publication Date
SK42897A3 true SK42897A3 (en) 1997-10-08

Family

ID=7790501

Family Applications (1)

Application Number Title Priority Date Filing Date
SK428-97A SK42897A3 (en) 1996-04-04 1997-04-03 Process for producing enantiomerically clean cycloalkano indol- and azaindol-, and pyrimido£1,2-a|indolcarboxylic acids, and their activated derivatives, intermediate products for this process and their use

Country Status (27)

Country Link
US (1) US5952498A (ja)
EP (1) EP0799829B1 (ja)
JP (2) JP4235268B2 (ja)
KR (1) KR970069988A (ja)
CN (2) CN1067394C (ja)
AR (2) AR006544A1 (ja)
AT (1) ATE246193T1 (ja)
AU (1) AU722592B2 (ja)
BR (1) BR9701672A (ja)
CA (1) CA2201435C (ja)
CZ (1) CZ102197A3 (ja)
DE (2) DE19613549A1 (ja)
DZ (1) DZ2202A1 (ja)
EE (1) EE9700079A (ja)
ES (1) ES2202506T3 (ja)
HR (1) HRP970178A2 (ja)
HU (1) HU218494B (ja)
ID (1) ID16794A (ja)
IL (1) IL120591A (ja)
MA (1) MA24130A1 (ja)
NO (2) NO308301B1 (ja)
NZ (1) NZ314498A (ja)
PL (1) PL319269A1 (ja)
SG (1) SG60050A1 (ja)
SK (1) SK42897A3 (ja)
TN (1) TNSN97060A1 (ja)
ZA (1) ZA972831B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435477A1 (de) 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
AU2001244635A1 (en) * 2000-03-30 2001-10-15 Yamanouchi Pharmaceutical Co..Ltd. Hydrazide derivatives
WO2005051382A1 (ja) * 2003-11-28 2005-06-09 Astellas Pharma Inc. 脂質低下作用増強剤
WO2005087234A1 (en) * 2004-03-05 2005-09-22 The Trustees Of The University Of Pennsylvania Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects
AU2005230397B2 (en) * 2004-04-09 2010-04-08 Elanco Animal Health Ireland Limited Intermittent dosing regimen for the treatment of overweight with MTP-inhibitors
EP1951220A2 (en) * 2005-10-18 2008-08-06 Aegerion Pharmaceuticals Compositions for lowering serum cholesterol and/or triglycerides
US20080051427A1 (en) * 2006-05-18 2008-02-28 Fritz Schuckler Pharmaceutical Compositions and Methods of Using Same
WO2008079398A1 (en) * 2006-12-21 2008-07-03 Aegerion Pharmaceuticals, Inc. Methods for treating obesity with a combination comprising a mtp inhibitor and a cholesterol absorption inhibitor
WO2008124384A2 (en) * 2007-04-03 2008-10-16 Aegerion Pharmaceuticals, Inc. Combinations of mtp inhibitors with cholesterol absorption inhibitors or interferon for treating hepatitis c
JP6721499B2 (ja) 2013-03-14 2020-07-15 オステオーク インコーポレイティド 骨の成長を促進するためのアルキルアミンハルミン誘導体
MX2021001752A (es) 2018-08-14 2021-06-23 Osteoqc Inc Compuestos de pirrolo-dipiridina.
AU2019320773A1 (en) 2018-08-14 2021-03-04 Osteoqc Inc. Fluoro β-carboline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
DE4302956A1 (de) * 1993-02-03 1994-08-04 Bayer Ag Substituierte Imidazo(4,5-b)pyridine und Benzimidazole
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate

Also Published As

Publication number Publication date
JP4235268B2 (ja) 2009-03-11
CN1184109A (zh) 1998-06-10
BR9701672A (pt) 1998-11-03
NO971513L (no) 1997-10-06
EP0799829B1 (de) 2003-07-30
ZA972831B (en) 1997-10-31
HUP9700698A1 (hu) 1998-01-28
KR970069988A (ko) 1997-11-07
NZ314498A (en) 1999-09-29
DE19613549A1 (de) 1997-10-09
CN1330065A (zh) 2002-01-09
EE9700079A (et) 1997-10-15
NO20003784L (no) 1997-10-06
NO308301B1 (no) 2000-08-28
NO20003784D0 (no) 2000-07-24
HU9700698D0 (en) 1997-05-28
MX9702446A (es) 1997-10-31
MA24130A1 (fr) 1997-10-01
JPH1045759A (ja) 1998-02-17
AU1660297A (en) 1997-10-09
NO971513D0 (no) 1997-04-03
DZ2202A1 (fr) 2002-12-03
CZ102197A3 (en) 1997-10-15
HRP970178A2 (en) 1998-04-30
HU218494B (hu) 2000-09-28
EP0799829A1 (de) 1997-10-08
ID16794A (id) 1997-11-13
CA2201435C (en) 2006-12-12
DE59710487D1 (de) 2003-09-04
AR012048A2 (es) 2000-09-27
IL120591A (en) 2000-11-21
PL319269A1 (en) 1997-10-13
US5952498A (en) 1999-09-14
AU722592B2 (en) 2000-08-10
SG60050A1 (en) 1999-02-22
JP2008169218A (ja) 2008-07-24
IL120591A0 (en) 1997-08-14
TNSN97060A1 (fr) 2005-03-15
ES2202506T3 (es) 2004-04-01
ATE246193T1 (de) 2003-08-15
CN1067394C (zh) 2001-06-20
AR006544A1 (es) 1999-09-08
CA2201435A1 (en) 1997-10-04

Similar Documents

Publication Publication Date Title
JP2008169218A (ja) エナンチオマー的に純粋なシクロアルカノ−インドール−、アザインドール−またはピリミド［１，２ａ］インドール−カルボン酸の中間体
JP5000841B2 (ja) クロピドグレルの製造方法
MX2010010157A (es) Moduladores del receptor de prostaciclina (pg12) utiles para el tratamiento de trastornos relacionados con este.
AU653007B2 (en) Pyrazolopyridine compound and processes for preparation thereof
BR122020001312B1 (pt) Processo para preparação de 5-flúor-1h-pirazolopiridinas substituídas, e compostos intermediários
EP0406112B1 (fr) 1-Benzhydrylazétidines, leur préparation et leur application comme intermédiaires pour la préparation de composés à activité antimicrobienne
JP2005527531A5 (ja)
US6774236B1 (en) Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives
JPWO2020050339A1 (ja) シクロプロパン化合物の製造方法
MXPA04010765A (es) Procedimiento para la preparacion de clopidogrel.
FR2649394A1 (fr) Derives d'azulene, antagonistes des recepteurs d'endoperoxydes du thromboxane a2 et des prostaglandines, et leur procede de preparation
JP2769058B2 (ja) シクロプロパン誘導体の製法
MXPA97002446A (en) Procedure for the preparation of acids cicloalcano-indol- and pirimido- [1,2a] indol-carboxilicosanantiomeros puros and their active derivatives
JPH04334370A (ja) ラセミおよび光学活性１，２，３，４−テトラヒドロイソキノリン−３−カルボン酸およびその前駆体の製造方法
EP2146954B1 (fr) Procede de synthese de l'acide (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl]-2-methoxy-acrylique
JPH09255656A (ja) スルフォンアミド誘導体及びこれを含有する医薬
CZ163693A3 (en) Novel isobutyl substituted amides of methanesulfonyl-quinolylmethoxyphenyl-cycloalkylacetic acid
DK161318B (da) Fremgangsmaade til fremstilling af 4-acetyl-2-(alkyl eller aralkyl)imidazoler og 2-chlor-1,1-dialkoxy-3-butanoner til anvendelse som mellemprodukter derved
JP3283959B2 (ja) Ｄ−ビオチン中間体およびその製造法
JPH04112852A (ja) ハロアルキルオキシ酢酸誘導体の製造法
JP2000007609A (ja) カルボン酸誘導体の製造法
JP2002047269A (ja) ヘテロ環化合物の製造方法およびその中間体
JPH0741478A (ja) ピラゾロトリアゾール誘導体の製造法
MXPA00002872A (en) Processes and intermediates useful to make antifolates
PL209522B1 (pl) Sposób wytwarzania związku pirydonowego